Quantification of Subtype Purity in Luminal A Breast Cancer Predicts Clinical Characteristics and Survival

Neeraj Kumar, Peter H. Gann, Stephanie M. McGregor, Amit Sethi
doi: https://doi.org/10.1101/2023.02.27.23286511

Article Information

doi 
https://doi.org/10.1101/2023.02.27.23286511
History 
  • March 1, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Neeraj Kumar1,
  2. Peter H. Gann2,
  3. Stephanie M. McGregor3 and
  4. Amit Sethi2,4,*
  1. 1Alberta Machine Intelligence Institute, Edmonton, Alberta, CANADA
  2. 2Department of Pathology, College of Medicine, University of Illinois at Chicago University of Illinois Cancer Center, Chicago, IL, USA
  3. 3University of Wisconsin-Madison, Department of Pathology and Laboratory Medicine University of Wisconsin Carbone Cancer Center, Madison, WI, USA
  4. 4Department of Electrical Engineering, Indian Institute of Technology Bombay, Mumbai, INDIA
  1. ↵*Corresponding author: Amit Sethi, PhD asethi{at}iitb.ac.in
Back to top
Posted March 01, 2023.
Download PDF
Data/Code
Email
Quantification of Subtype Purity in Luminal A Breast Cancer Predicts Clinical Characteristics and Survival
Neeraj Kumar, Peter H. Gann, Stephanie M. McGregor, Amit Sethi
medRxiv 2023.02.27.23286511; doi: https://doi.org/10.1101/2023.02.27.23286511
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area